Finally, forced expression of MKX in AML cell line HL-60 suppressed GATA2 and BCL2L11, and activated SESN3 (Fig 5F), confirming the regulatory impact observed in OCI-AML3. The gene discussed is BCL2L11; the disease is acute myeloid leukemia.